Physician Leadership on National Drug Policy
July 9, 1997
Addiction to illegal drugs is a major national problem that creates impaired health, harmful behaviors, and major economic and social
burdens. Addiction to illegal drugs is a chronic illness. Addiction treatment requires continuity of care, including acute and follow-up care strategies, management of any relapses, and satisfactory outcome
We are impressed by the growing body of evidence that enhanced medical and public health approaches are the most effective method of
reducing harmful use of illegal drugs. These approaches offer great opportunities to decrease the burden on individuals and communities, particularly when they are integrated into multidisciplinary and collaborative
approaches. The current emphasis -- on use of the criminal justice system and interdiction to reduce illegal drug use and the harmful effects of illegal drugs -- is not adequate to address these problems.
The abuse of tobacco and alcohol is also a critically important national problem. We strongly support efforts to reduce tobacco use, including changes
in the regulatory environment and tax policy. Abuse of alcohol causes a substantial burden of disease and antisocial behavior which requires vigorous, widely accessible treatment and prevention programs. Despite the
gravity of problems caused by tobacco and alcohol, we are focusing our attention on illicit drugs because of the need for fundamental shift in policy.
As physicians we believe that:
- It is time for a new emphasis in our national drug policy by substantially refocusing our investment in the prevention and treatment of harmful
drug use. This requires reallocating resources toward drug treatment and prevention, utilizing criminal justice procedures which are shown to be effective in reducing supply and demand, and reducing the
disabling regulation of addiction treatment programs.
- Concerted efforts to eliminate the stigma associated with the diagnosis and treatment of drug problems are essential. Substance abuse should be
accorded parity with other chronic, relapsing conditions insofar as access to care, treatment benefits, and clinical outcomes are concerned.
- Physicians and all other health professionals have a major responsibility to train themselves and their students to be clinically competent in
- Community-based health partnerships are essential to solve these problems.
- New research opportunities produced by advances in the understanding of the biological and behavioral aspects of drugs and addiction, as well as
research on the outcomes of prevention and treatment programs, should be exploited by expanding investments in research and training.
Over the next year, Physician Leadership on National Drug Policy will review the evidence to identify and recommend medical and public
health approaches that are likely to be more cost-effective, in both human and economic terms. We shall also encourage our respective professional organizations to endorse and implement these policies